Insmed Inc Stock Price on December 31, 2022
| INSM Stock | USD 79.05 0.95 1.22% |
Below is the normalized historical share price chart for Insmed Inc extending back to February 15, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Insmed stands at 79.05, as last reported on the 27th of February, with the highest price reaching 81.11 and the lowest price hitting 78.00 during the day.
If you're considering investing in Insmed Stock, it is important to understand the factors that can impact its price. As of now, Insmed Stock is very steady. Insmed Inc holds Efficiency (Sharpe) Ratio of 0.0608, which attests that the entity had a 0.0608 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Insmed Inc, which you can use to evaluate the volatility of the firm. Please check out Insmed's Market Risk Adjusted Performance of 0.2189, downside deviation of 1.98, and Risk Adjusted Performance of 0.0442 to validate if the risk estimate we provide is consistent with the expected return of 0.14%.
At this time, Insmed's Issuance Of Capital Stock is very stable compared to the past year. As of the 27th of February 2025, Stock Based Compensation To Revenue is likely to grow to 0.37, while Capital Stock is likely to drop about 1.3 M. . At this time, Insmed's Price Book Value Ratio is very stable compared to the past year. As of the 27th of February 2025, Price To Book Ratio is likely to grow to 41.67, while Price Earnings Ratio is likely to drop (13.01). Insmed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of June 2000 | 200 Day MA 69.0334 | 50 Day MA 74.6598 | Beta 1.115 |
Insmed |
Sharpe Ratio = 0.0608
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | INSM | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.26 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Insmed is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Insmed by adding it to a well-diversified portfolio.
Price Book 49.1538 | Enterprise Value Ebitda (6.05) | Price Sales 38.8665 | Shares Float 166.4 M | Wall Street Target Price 95.3682 |
Related Headline
Apellis Pharmaceuticals Headline on 10th of February 2023
Payment of 551 shares by David Watson of Apellis Pharmaceuti... by David Watson
Filed transaction by Apellis Pharmaceuticals I officer. Payment of exercise price or tax liability by delivering or withholding securities
Insmed Valuation on December 31, 2022
It is possible to determine the worth of Insmed on a given historical date. On December 31, 2022 Insmed was worth 19.8 at the beginning of the trading date compared to the closed value of 19.62. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Insmed stock. Still, in general, we apply an absolute valuation method to find Insmed's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Insmed where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Insmed's related companies.
| Open | High | Low | Close | Volume | |
02/10/2023 | 19.80 | 19.96 | 19.40 | 19.62 | 851,462 |
| 19.67 | 19.97 | 19.46 | 19.83 | 1,623,919 |
| Backtest Insmed | | | Insmed History | | | Insmed Valuation | Next |
Insmed Trading Date Momentum on December 31, 2022
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Insmed Inc Fundamentals Correlations and Trends
By evaluating Insmed's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Insmed's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Insmed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Insmed Stock history
Insmed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Insmed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Insmed Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Insmed stock prices may prove useful in developing a viable investing in Insmed
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 164 M | 172.2 M | |
| Net Loss | -433.4 M | -411.7 M |
Insmed Quarterly Net Working Capital |
|
Insmed Stock Technical Analysis
Insmed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Insmed Period Price Range
Low | February 27, 2025
| High |
0.00 | 0.00 |
Insmed Inc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Insmed February 27, 2025 Market Strength
Market strength indicators help investors to evaluate how Insmed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Insmed shares will generate the highest return on investment. By undertsting and applying Insmed stock market strength indicators, traders can identify Insmed Inc entry and exit signals to maximize returns
Insmed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Insmed's price direction in advance. Along with the technical and fundamental analysis of Insmed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Insmed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0442 | |||
| Jensen Alpha | 0.1036 | |||
| Total Risk Alpha | 0.1195 | |||
| Sortino Ratio | 0.054 | |||
| Treynor Ratio | 0.2089 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.62) | Revenue Per Share | Quarterly Revenue Growth 0.248 | Return On Assets | Return On Equity |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.